{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.205","meta":{"versionId":"3","lastUpdated":"2015-09-11T01:00:03.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.205","version":"20150911","name":"Fulvestrant","status":"active","date":"2015-09-11T01:00:03-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"350934","display":"fulvestrant 50 MG/ML"},{"code":"575925","display":"fulvestrant 50 MG/ML [Faslodex]"},{"code":"727761","display":"2.5 ML fulvestrant 50 MG/ML Prefilled Syringe"},{"code":"727762","display":"5 ML fulvestrant 50 MG/ML Prefilled Syringe"},{"code":"727954","display":"5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex]"}]}]}}